Abstract
Background Perinatal stroke injures motor regions of the brain, compromising movement for life. Early, intensive, active interventions for the upper extremity are efficacious, but interventions for the lower extremity (LE) remain infrequent and understudied.
Objective To determine the efficacy of ELEVATE – Engaging the Lower Extremity Via Active Therapy Early - on gross motor function, as compared to usual care.
Method We conducted a single-blind, two-arm, randomized controlled trial (RCT), with the Immediate Group receiving the intervention while the Delay Group served as a three-month waitlist-control. A separate cohort living beyond commuting distance was trained by their parents with guidance from physical therapists. Participants were 8 months to 3 years old, with MRI-confirmed perinatal ischemic stroke and early signs of hemiparesis. The intervention was play-based, focused on weight-bearing, balance and walking for 1 hour/day, 4 days/week for 12 weeks. The primary outcome was the Gross Motor Function Measure-66 (GMFM-66). Secondary outcomes included steps and gait analyses. Final follow-up occurred at age four.
Results Thirty-four children participated (25 RCT, 9 Parent-trained). The improvement in GMFM-66 over 12 weeks was greater for the Immediate than the Delay Group (average change 3.4 units higher) and greater in younger children. Average step counts reached 1370–3750 steps/session in the last week of training for all children. Parent-trained children also improved but with greater variability.
Conclusions Early, activity-intensive LE therapy for young children with perinatal stroke is feasible and improves gross motor function in the short term. Longer term improvement may require additional bouts of intervention.
Clinical trial registratio This study was registered at ClinicalTrials.gov (NCT01773369).
- neuroplasticity
- rehabilitation
- early intervention
- cerebral palsy
- motor skill training
- intensive training
- exercise
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT01773369
Clinical Protocols
https://academic.oup.com/ptj/article/97/8/818/3803379
Funding Statement
This work was supported by the Canadian Institutes of Health Research [MOP 126107], Alberta Innovates Health Solutions [Collaborative Research and Innovation Opportunities Project Funding #201200830], and CH was awarded a Women and Children's Health Research Institute (WCHRI) graduate studentship that has been funded through the generous support of the Stollery Children's Hospital Foundation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
REB3 - Health Research Ethics Board - Health Panel, University of Alberta
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data will be made available once the manuscript has been accepted for publication by a peer-reviewed journal.